Search results
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
CTI BioPharma (CTIC) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 year agoCTI BioPharma (CTIC) delivered earnings and revenue surprises of 13.33% and 0.64%, respectively, for...
Will CTI BioPharma (CTIC) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 12 months agoCTI BioPharma (CTIC) doesn't possess the right combination of the two key ingredients for a likely...
12 Best Multibagger Stocks to Buy Now
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss 12 best multibagger stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Multibagger Stocks...
Why CTI BioPharma Stock Crushed the Market Today
Motley Fool· 2 years agoThe stock market as a whole had a fine Monday, but CTI BioPharma (NASDAQ: CTIC) had a particularly good time of it. The China-based biotech's shares...
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
Benzinga via Yahoo Finance· 2 years agoSVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ: CTIC) with an Outperform rating and a...
Why CTI Biopharma Stock Is Surging Today
Motley Fool· 2 years agoShares of CTI BioPharma (NASDAQ: CTIC) moved sharply higher after the drugmaker reported first-quarter results Friday morning. Investors were pleased...
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
Benzinga via Yahoo Finance· 12 months agoSwedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for...
Why CTI BioPharma Stock Withered on Wednesday
Motley Fool· 2 years agoIn contrast to many other biotechs, CTI stock has done fairly well this year -- in fact, it has nearly doubled since the beginning of this year. This...
CTI BioPharma: Q1 Earnings Snapshot
AP Finance via Yahoo Finance· 11 months agoSEATTLE (AP) — SEATTLE (AP) — CTI BioPharma Corp. (CTIC) on Monday reported a loss of $13.4 million in its first quarter. The Seattle-based company said it had a loss of 10 cents per share.
